Yvan Verlinden

Susceptibility of Human Immunodeficiency Virus Type 1 to the Maturation Inhibitor Bevirimat Is Modulated by Baseline Polymorphisms in Gag Spacer Peptide 1

Kurt Van Baelen, Karl Salzwedel, Evelien Rondelez et al. · Antimicrobial Agents and Chemotherapy · 2009 · 88 citations · Full text

Life Sciences, Infectious Diseases, Molecular Genetics +17

Resistance-Associated Mutations to Etravirine (TMC-125) in Antiretroviral-Naive Patients Infected with Non-B HIV-1 Subtypes

Almoustapha Issiaka Maïga, Diane Descamps, Laurence Morand‐Joubert et al. · Antimicrobial Agents and Chemotherapy · 2009 · 41 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

The antiviral compound 5-(3,4-dichlorophenyl) methylhydantoin inhibits the post-synthetic cleavages and the assembly of poliovirus in a cell-free system

Yvan Verlinden, Andrea Cuconati, Eckard Wimmer et al. · Antiviral Research · 2000 · 40 citations

Life Sciences, Molecular Biology, Pharmacology +11

Cell-free synthesis of poliovirus: 14S subunits are the key intermediates in the encapsidation of poliovirus RNA

Yvan Verlinden, Andrea Cuconati, Eckard Wimmer et al. · Journal of General Virology · 2000 · 30 citations

Life Sciences, Microbiology, Molecular Biology +12

Development and Performance of Conventional HIV-1 Phenotyping (Antivirogram®) and Genotype-Based Calculated Phenotyping Assay (virco®TYPE HIV-1) on Protease and Reverse Transcriptase Genes to Evaluate Drug Resistance

Theresa Pattery, Yvan Verlinden, Hans Wolf et al. · Intervirology · 2012 · 21 citations · Full text

Life Sciences, Microbiology, Pharmacology +17